Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension
Condition: Essential Hypertension Interventions: Drug: SPH3127 tablet; Drug: Valsartan Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
